>>14147548 (lb)
>Moderna said in mid-April that its vaccine study in adolescents is now fully enrolled, with around 3,000 people ages 12 to 17 slated to receive doses.
A second phase of the study will follow, including children who are from 6 months to 11 years old.
Pharmaceutical outfits, economically, understand if they can get FDA approval, then they could tap into the 6 months to 11 year old 'forced' jab
market making moar money then they ever could inoculating teens and adults.